Retatrutide once weekly at a consistent time, Tesamorelin daily in the evening
We emphasize consistent adherence, as the dual-action GIP and GLP-1 receptor agonism works best with regular, scheduled administration
The direct cardiovascular effects represent a combination of platelet inhibition, augmented fibrinolytic responses, and attenuated thrombogenesis that collectively address not only the prothrombotic phenotypes of DM mellitus, obesity, and chronic kidney disease but a novel prevention approach beyond traditional risk factors for myocardial infarction, ischemic stroke, and cardiovascular death [90, 91]
This reduces atherosclerosis risk (accumulation of plaque that causes heart attack and stroke.)
Ideal for overall wellness and beauty enhancement
Is a Certificate of Analysis provided